The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1003474
WO Application Number:
US1998002701
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP98907434.9
WO Publication Number:
WO1998034593
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
06/02/1998
Grant date:
15/04/2009
EP Publication Date:
15/04/2009
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/04/2009
EP B1 Publication Date:
15/04/2009
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/02/2018
Lapsed By Expiration Date:
06/02/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
23/12/2014
Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, Rahway, NJ 07065, United States of America (US)
Historical Applicant/holder
From:
15/04/2009
To:
23/12/2014
Name:
Inspire Pharmaceuticals, Inc.
Address:
4222 Emperior Boulevard, suite 470, 27703, Durham, North Carolina, United States of America (US)
Domicile Holder
Name:
E. Vaeck
From:
15/04/2009
Address:
De Clercq & Partners
Edgard Gevaertdreef 10 a, B-9830, Sint-Martens-Latem, Belgium (BE)